AGIO
USDAgios Pharmaceuticals Inc. Common Stock
$39.440+0.110 (0.280%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$39.330
High
$40.320
Low
$38.900
Volume
0.19M
Company Fundamentals
Market Cap
2.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.65M
Exchange
NMS
Currency
USD
52-Week Range
Low $23.42Current $39.440High $62.58
Related News
GlobeNewswire
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases,
View more
GlobeNewswire
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update
$12.9 million in third quarter PYRUKYND® (mitapivat) net revenuesPDUFA goal date for PYRUKYND U.S. sNDA in thalassemia set for December 7, 2025CHMP adopted positive opinion for PYRUKYND in thalassemia; EC decision
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.